🦊/Lists

Biotech Investors & VC Firms in United States

1280 firms in this list, with a median first check of $500K. 281 of them lead rounds. Generated from verified public data and updated continuously.

Monograph Capital Partners
LondonSeed–Series B
23 people
Morningside Venture Capital Limited
ShanghaiPre-Seed–Growth$5M – $400M
Catalys Pacific
TokyoSeed–Series A
26 people
Systemiq Capital
LondonSeries A–Growth
16 people
MVM Life Science Partners
LondonSeed–Late Stage$20M – $100M
20 people
Blue Horizon Corporation
ZurichPre-Seed–Late Stage
Enterprise Investors Sp. z o. o.
WarsawSeries A–Growth$21.6M – $81M
31 people
ScaleX Ventures
AmsterdamSeed–Series A$216K – $2.2M
13 people
Heal Capital
BerlinPre-Seed–Late Stage$1M – $5M
15 people
IT-Farm Corporation
TokyoSeed–Series A
1 person
Blue Ocean Capital Group
ShenzhenLate Stage
23 people
Miyako Capital
KyotoPre-Seed–Late Stage
14 people
Georgian
Toronto, OntarioSeries B–Late Stage$25M – $100M
12 people
Galion.exe
Seed$275K – $2.8M
16 people
Xeraya Capital
Kuala LumpurSeed–Growth
24 people
Quantonation
ParisPre-Seed–Series B
13 people
Debiopharm Innovation Fund
LausannePre-Seed–Late Stage$1M – $5M
18 people
Nextech Invest
ZurichSeed–Late Stage$648K – $3.2M
3 people
Exceptional Ventures
LondonPre-Seed–Series A
16 people
LVX Ventures
BangalorePre-Seed–Late Stage$179K – $10M
Creator Fund
LondonPre-Seed–Series A$1.1M
20 people
Droia Ventures
LuxembourgPre-Seed–Series B$540K
13 people
Thorney Investment Group
MelbourneSeed–Late Stage
25 people
GSR United Capital
BeijingSeed–Late Stage$98K – $50M

Related lists

Data sourced from public filings and firms' own websites — see our methodology.